A mathematical model for the immunotherapeutic control of the Th1/Th2 imbalance in melanoma
From MaRDI portal
Publication:378949
Recommendations
- Response of patients with melanoma to immune checkpoint blockade -- insights gleaned from analysis of a new mathematical mechanistic model
- Modeling anti-tumor Th1 and Th2 immunity in the rejection of melanoma
- Tumor control, elimination, and escape through a compartmental model of dendritic cell therapy for melanoma
- Treatment of melanoma with dendritic cell vaccines and immune checkpoint inhibitors: a mathematical modeling study
- Mathematical modeling of tumor-induced immunosuppression by myeloid-derived suppressor cells: implications for therapeutic targeting strategies
Cited in
(17)- A dynamical model of the immune system interaction in a melanoma
- Tumor control, elimination, and escape through a compartmental model of dendritic cell therapy for melanoma
- Modelling of killer T-cell and cancer cell subpopulation dynamics under immuno- and chemotherapies
- Mathematical modeling of allergy and specific immunotherapy: Th1-Th2-Treg interactions
- Treatment of Psoriasis by Interleukin-10 Through Impulsive Control Strategy: A Mathematical Study
- A vivid cytokines interaction model on psoriasis with the effect of impulse biologic (\(\mathrm{TNF}-\alpha\) inhibitor) therapy
- Optimal control problem for a general reaction-diffusion tumor-immune interaction system of mixed immunotherapy and chemotherapy
- Response of patients with melanoma to immune checkpoint blockade -- insights gleaned from analysis of a new mathematical mechanistic model
- Mathematical insights on psoriasis regulation: role of \(\mathrm{Th}_{1}\) and \(\mathrm{Th}_{2}\) cells
- The re-polarisation of M2 and M1 macrophages and its role on cancer outcomes
- Mathematics + cancer: an undergraduate ``bridge course in applied mathematics
- A model of the optimal immunotherapy of psoriasis by introducing IL-10 and IL-22 inhibitors
- Modelling of tumor cells regression in response to chemotherapeutic treatment
- Dynamic analysis of the melanoma model: from cancer persistence to its eradication
- Modeling anti-tumor Th1 and Th2 immunity in the rejection of melanoma
- Modelling and investigation of the \(\mathrm{CD}4^+\) T cells -- macrophages paradox in melanoma immunotherapies
- When is allergen immunotherapy effective?
This page was built for publication: A mathematical model for the immunotherapeutic control of the Th1/Th2 imbalance in melanoma
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q378949)
